nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—peripheral nervous system neoplasm—skin cancer	0.541	1	CtDrD
Topotecan—ABCG2—Vismodegib—skin cancer	0.0757	0.215	CbGbCtD
Topotecan—ABCG2—Vemurafenib—skin cancer	0.0598	0.17	CbGbCtD
Topotecan—ABCG2—Dactinomycin—skin cancer	0.0398	0.113	CbGbCtD
Topotecan—ABCB1—Vismodegib—skin cancer	0.0273	0.0774	CbGbCtD
Topotecan—ABCG2—Fluorouracil—skin cancer	0.0269	0.0762	CbGbCtD
Topotecan—CYP3A4—Temozolomide—skin cancer	0.0236	0.0669	CbGbCtD
Topotecan—CYP3A4—Imiquimod—skin cancer	0.0236	0.0669	CbGbCtD
Topotecan—ABCG2—Docetaxel—skin cancer	0.0205	0.0582	CbGbCtD
Topotecan—CYP3A4—Vismodegib—skin cancer	0.0164	0.0464	CbGbCtD
Topotecan—ABCB1—Dactinomycin—skin cancer	0.0143	0.0406	CbGbCtD
Topotecan—CYP3A4—Vemurafenib—skin cancer	0.0129	0.0366	CbGbCtD
Topotecan—ABCB1—Docetaxel—skin cancer	0.0074	0.021	CbGbCtD
Topotecan—CYP3A4—Docetaxel—skin cancer	0.00444	0.0126	CbGbCtD
Topotecan—TOP1—hair follicle—skin cancer	0.00065	0.215	CbGeAlD
Topotecan—TOP1—nipple—skin cancer	0.000441	0.146	CbGeAlD
Topotecan—TOP1MT—female reproductive system—skin cancer	0.000418	0.139	CbGeAlD
Topotecan—TOP1MT—head—skin cancer	0.000349	0.116	CbGeAlD
Topotecan—TOP1—mammalian vulva—skin cancer	0.000257	0.0853	CbGeAlD
Topotecan—TOP1MT—lymph node—skin cancer	0.000244	0.081	CbGeAlD
Topotecan—Body temperature increased—Vemurafenib—skin cancer	0.0002	0.00193	CcSEcCtD
Topotecan—Pharyngitis—Dactinomycin—skin cancer	0.000199	0.00193	CcSEcCtD
Topotecan—Pancytopenia—Fluorouracil—skin cancer	0.000199	0.00192	CcSEcCtD
Topotecan—Neuropathy peripheral—Temozolomide—skin cancer	0.000198	0.00192	CcSEcCtD
Topotecan—Stomatitis—Temozolomide—skin cancer	0.000197	0.00191	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000196	0.0019	CcSEcCtD
Topotecan—Paraesthesia—Imiquimod—skin cancer	0.000193	0.00187	CcSEcCtD
Topotecan—Chills—Bleomycin—skin cancer	0.000193	0.00187	CcSEcCtD
Topotecan—Dyspnoea—Imiquimod—skin cancer	0.000192	0.00185	CcSEcCtD
Topotecan—Hepatobiliary disease—Temozolomide—skin cancer	0.000191	0.00185	CcSEcCtD
Topotecan—Alopecia—Bleomycin—skin cancer	0.00019	0.00184	CcSEcCtD
Topotecan—Dyspepsia—Imiquimod—skin cancer	0.00019	0.00183	CcSEcCtD
Topotecan—Pneumonia—Fluorouracil—skin cancer	0.000188	0.00181	CcSEcCtD
Topotecan—Decreased appetite—Imiquimod—skin cancer	0.000187	0.00181	CcSEcCtD
Topotecan—Infestation NOS—Fluorouracil—skin cancer	0.000187	0.0018	CcSEcCtD
Topotecan—Infestation—Fluorouracil—skin cancer	0.000187	0.0018	CcSEcCtD
Topotecan—Hypersensitivity—Vemurafenib—skin cancer	0.000186	0.0018	CcSEcCtD
Topotecan—Gastrointestinal disorder—Imiquimod—skin cancer	0.000186	0.0018	CcSEcCtD
Topotecan—Fatigue—Imiquimod—skin cancer	0.000186	0.00179	CcSEcCtD
Topotecan—Pain—Imiquimod—skin cancer	0.000184	0.00178	CcSEcCtD
Topotecan—Neuropathy peripheral—Fluorouracil—skin cancer	0.000183	0.00177	CcSEcCtD
Topotecan—Dermatitis bullous—Docetaxel—skin cancer	0.000183	0.00176	CcSEcCtD
Topotecan—Haemoglobin—Temozolomide—skin cancer	0.000183	0.00176	CcSEcCtD
Topotecan—Stomatitis—Fluorouracil—skin cancer	0.000182	0.00176	CcSEcCtD
Topotecan—Haemorrhage—Temozolomide—skin cancer	0.000182	0.00175	CcSEcCtD
Topotecan—Asthenia—Vemurafenib—skin cancer	0.000181	0.00175	CcSEcCtD
Topotecan—Hypoaesthesia—Temozolomide—skin cancer	0.000181	0.00175	CcSEcCtD
Topotecan—Pharyngitis—Temozolomide—skin cancer	0.00018	0.00174	CcSEcCtD
Topotecan—Chills—Dactinomycin—skin cancer	0.00018	0.00174	CcSEcCtD
Topotecan—Pruritus—Vemurafenib—skin cancer	0.000179	0.00173	CcSEcCtD
Topotecan—Lethargy—Docetaxel—skin cancer	0.000178	0.00172	CcSEcCtD
Topotecan—Alopecia—Dactinomycin—skin cancer	0.000178	0.00171	CcSEcCtD
Topotecan—Feeling abnormal—Imiquimod—skin cancer	0.000178	0.00171	CcSEcCtD
Topotecan—Gastrointestinal pain—Imiquimod—skin cancer	0.000176	0.0017	CcSEcCtD
Topotecan—Epistaxis—Fluorouracil—skin cancer	0.000176	0.0017	CcSEcCtD
Topotecan—Ill-defined disorder—Bleomycin—skin cancer	0.000174	0.00168	CcSEcCtD
Topotecan—Anaemia—Bleomycin—skin cancer	0.000173	0.00167	CcSEcCtD
Topotecan—Diarrhoea—Vemurafenib—skin cancer	0.000173	0.00167	CcSEcCtD
Topotecan—Urticaria—Imiquimod—skin cancer	0.000171	0.00165	CcSEcCtD
Topotecan—Abdominal pain—Imiquimod—skin cancer	0.00017	0.00164	CcSEcCtD
Topotecan—Body temperature increased—Imiquimod—skin cancer	0.00017	0.00164	CcSEcCtD
Topotecan—Malaise—Bleomycin—skin cancer	0.000169	0.00163	CcSEcCtD
Topotecan—Haemoglobin—Fluorouracil—skin cancer	0.000168	0.00162	CcSEcCtD
Topotecan—Leukopenia—Bleomycin—skin cancer	0.000168	0.00162	CcSEcCtD
Topotecan—Rhinitis—Fluorouracil—skin cancer	0.000168	0.00162	CcSEcCtD
Topotecan—Haemorrhage—Fluorouracil—skin cancer	0.000167	0.00162	CcSEcCtD
Topotecan—Dizziness—Vemurafenib—skin cancer	0.000167	0.00161	CcSEcCtD
Topotecan—Hypoaesthesia—Fluorouracil—skin cancer	0.000167	0.00161	CcSEcCtD
Topotecan—Pharyngitis—Fluorouracil—skin cancer	0.000166	0.0016	CcSEcCtD
Topotecan—Angiopathy—Temozolomide—skin cancer	0.000165	0.00159	CcSEcCtD
Topotecan—Immune system disorder—Temozolomide—skin cancer	0.000164	0.00158	CcSEcCtD
Topotecan—Mediastinal disorder—Temozolomide—skin cancer	0.000164	0.00158	CcSEcCtD
Topotecan—Cough—Bleomycin—skin cancer	0.000164	0.00158	CcSEcCtD
Topotecan—Chills—Temozolomide—skin cancer	0.000163	0.00157	CcSEcCtD
Topotecan—Ill-defined disorder—Dactinomycin—skin cancer	0.000162	0.00157	CcSEcCtD
Topotecan—Anaemia—Dactinomycin—skin cancer	0.000162	0.00156	CcSEcCtD
Topotecan—Vomiting—Vemurafenib—skin cancer	0.000161	0.00155	CcSEcCtD
Topotecan—Alopecia—Temozolomide—skin cancer	0.000161	0.00155	CcSEcCtD
Topotecan—Chest pain—Bleomycin—skin cancer	0.00016	0.00154	CcSEcCtD
Topotecan—Myalgia—Bleomycin—skin cancer	0.00016	0.00154	CcSEcCtD
Topotecan—Rash—Vemurafenib—skin cancer	0.000159	0.00154	CcSEcCtD
Topotecan—Dermatitis—Vemurafenib—skin cancer	0.000159	0.00154	CcSEcCtD
Topotecan—Hypersensitivity—Imiquimod—skin cancer	0.000159	0.00153	CcSEcCtD
Topotecan—Headache—Vemurafenib—skin cancer	0.000158	0.00153	CcSEcCtD
Topotecan—Malnutrition—Temozolomide—skin cancer	0.000158	0.00153	CcSEcCtD
Topotecan—Discomfort—Bleomycin—skin cancer	0.000158	0.00152	CcSEcCtD
Topotecan—Malaise—Dactinomycin—skin cancer	0.000158	0.00152	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000157	0.00152	CcSEcCtD
Topotecan—Cramp muscle—Docetaxel—skin cancer	0.000157	0.00152	CcSEcCtD
Topotecan—Leukopenia—Dactinomycin—skin cancer	0.000157	0.00151	CcSEcCtD
Topotecan—Asthenia—Imiquimod—skin cancer	0.000155	0.00149	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000154	0.00149	CcSEcCtD
Topotecan—Anaphylactic shock—Bleomycin—skin cancer	0.000153	0.00148	CcSEcCtD
Topotecan—Back pain—Temozolomide—skin cancer	0.000153	0.00148	CcSEcCtD
Topotecan—Pruritus—Imiquimod—skin cancer	0.000152	0.00147	CcSEcCtD
Topotecan—Infection—Bleomycin—skin cancer	0.000152	0.00147	CcSEcCtD
Topotecan—Nausea—Vemurafenib—skin cancer	0.00015	0.00145	CcSEcCtD
Topotecan—Thrombocytopenia—Bleomycin—skin cancer	0.00015	0.00145	CcSEcCtD
Topotecan—Myalgia—Dactinomycin—skin cancer	0.000149	0.00144	CcSEcCtD
Topotecan—Alopecia—Fluorouracil—skin cancer	0.000148	0.00143	CcSEcCtD
Topotecan—Diarrhoea—Imiquimod—skin cancer	0.000147	0.00142	CcSEcCtD
Topotecan—Discomfort—Dactinomycin—skin cancer	0.000147	0.00142	CcSEcCtD
Topotecan—Ill-defined disorder—Temozolomide—skin cancer	0.000147	0.00142	CcSEcCtD
Topotecan—Anaemia—Temozolomide—skin cancer	0.000146	0.00141	CcSEcCtD
Topotecan—Anorexia—Bleomycin—skin cancer	0.000146	0.00141	CcSEcCtD
Topotecan—Angioedema—Temozolomide—skin cancer	0.000145	0.0014	CcSEcCtD
Topotecan—Pancytopenia—Docetaxel—skin cancer	0.000143	0.00138	CcSEcCtD
Topotecan—Malaise—Temozolomide—skin cancer	0.000143	0.00138	CcSEcCtD
Topotecan—Dizziness—Imiquimod—skin cancer	0.000142	0.00138	CcSEcCtD
Topotecan—Infection—Dactinomycin—skin cancer	0.000142	0.00137	CcSEcCtD
Topotecan—Leukopenia—Temozolomide—skin cancer	0.000142	0.00137	CcSEcCtD
Topotecan—Neutropenia—Docetaxel—skin cancer	0.000141	0.00136	CcSEcCtD
Topotecan—Thrombocytopenia—Dactinomycin—skin cancer	0.00014	0.00135	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000139	0.00135	CcSEcCtD
Topotecan—Cough—Temozolomide—skin cancer	0.000138	0.00133	CcSEcCtD
Topotecan—Paraesthesia—Bleomycin—skin cancer	0.000137	0.00133	CcSEcCtD
Topotecan—Weight increased—Docetaxel—skin cancer	0.000137	0.00133	CcSEcCtD
Topotecan—Vomiting—Imiquimod—skin cancer	0.000137	0.00132	CcSEcCtD
Topotecan—Dyspnoea—Bleomycin—skin cancer	0.000136	0.00132	CcSEcCtD
Topotecan—Anorexia—Dactinomycin—skin cancer	0.000136	0.00131	CcSEcCtD
Topotecan—Rash—Imiquimod—skin cancer	0.000136	0.00131	CcSEcCtD
Topotecan—Dermatitis—Imiquimod—skin cancer	0.000136	0.00131	CcSEcCtD
Topotecan—Pneumonia—Docetaxel—skin cancer	0.000135	0.00131	CcSEcCtD
Topotecan—Headache—Imiquimod—skin cancer	0.000135	0.0013	CcSEcCtD
Topotecan—Anaemia—Fluorouracil—skin cancer	0.000135	0.0013	CcSEcCtD
Topotecan—Myalgia—Temozolomide—skin cancer	0.000135	0.0013	CcSEcCtD
Topotecan—Arthralgia—Temozolomide—skin cancer	0.000135	0.0013	CcSEcCtD
Topotecan—Infestation NOS—Docetaxel—skin cancer	0.000135	0.0013	CcSEcCtD
Topotecan—Infestation—Docetaxel—skin cancer	0.000135	0.0013	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000134	0.00129	CcSEcCtD
Topotecan—Discomfort—Temozolomide—skin cancer	0.000133	0.00128	CcSEcCtD
Topotecan—Decreased appetite—Bleomycin—skin cancer	0.000133	0.00128	CcSEcCtD
Topotecan—Neuropathy peripheral—Docetaxel—skin cancer	0.000132	0.00127	CcSEcCtD
Topotecan—Stomatitis—Docetaxel—skin cancer	0.000131	0.00127	CcSEcCtD
Topotecan—Pain—Bleomycin—skin cancer	0.000131	0.00126	CcSEcCtD
Topotecan—Leukopenia—Fluorouracil—skin cancer	0.00013	0.00126	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00013	0.00126	CcSEcCtD
Topotecan—Anaphylactic shock—Temozolomide—skin cancer	0.000129	0.00125	CcSEcCtD
Topotecan—TOP1—lymph node—skin cancer	0.000129	0.0427	CbGeAlD
Topotecan—Infection—Temozolomide—skin cancer	0.000128	0.00124	CcSEcCtD
Topotecan—Nausea—Imiquimod—skin cancer	0.000128	0.00124	CcSEcCtD
Topotecan—Hepatobiliary disease—Docetaxel—skin cancer	0.000127	0.00123	CcSEcCtD
Topotecan—Epistaxis—Docetaxel—skin cancer	0.000127	0.00123	CcSEcCtD
Topotecan—Nervous system disorder—Temozolomide—skin cancer	0.000127	0.00122	CcSEcCtD
Topotecan—Thrombocytopenia—Temozolomide—skin cancer	0.000126	0.00122	CcSEcCtD
Topotecan—Feeling abnormal—Bleomycin—skin cancer	0.000126	0.00122	CcSEcCtD
Topotecan—Skin disorder—Temozolomide—skin cancer	0.000125	0.00121	CcSEcCtD
Topotecan—Hyperhidrosis—Temozolomide—skin cancer	0.000125	0.00121	CcSEcCtD
Topotecan—Chest pain—Fluorouracil—skin cancer	0.000124	0.0012	CcSEcCtD
Topotecan—Myalgia—Fluorouracil—skin cancer	0.000124	0.0012	CcSEcCtD
Topotecan—Decreased appetite—Dactinomycin—skin cancer	0.000124	0.0012	CcSEcCtD
Topotecan—Fatigue—Dactinomycin—skin cancer	0.000123	0.00119	CcSEcCtD
Topotecan—Anorexia—Temozolomide—skin cancer	0.000123	0.00119	CcSEcCtD
Topotecan—Discomfort—Fluorouracil—skin cancer	0.000123	0.00118	CcSEcCtD
Topotecan—Pain—Dactinomycin—skin cancer	0.000122	0.00118	CcSEcCtD
Topotecan—Urticaria—Bleomycin—skin cancer	0.000122	0.00117	CcSEcCtD
Topotecan—Haemoglobin—Docetaxel—skin cancer	0.000121	0.00117	CcSEcCtD
Topotecan—Rhinitis—Docetaxel—skin cancer	0.000121	0.00117	CcSEcCtD
Topotecan—Body temperature increased—Bleomycin—skin cancer	0.000121	0.00117	CcSEcCtD
Topotecan—Haemorrhage—Docetaxel—skin cancer	0.000121	0.00117	CcSEcCtD
Topotecan—Hypoaesthesia—Docetaxel—skin cancer	0.00012	0.00116	CcSEcCtD
Topotecan—Pharyngitis—Docetaxel—skin cancer	0.00012	0.00116	CcSEcCtD
Topotecan—Anaphylactic shock—Fluorouracil—skin cancer	0.000119	0.00115	CcSEcCtD
Topotecan—Infection—Fluorouracil—skin cancer	0.000118	0.00114	CcSEcCtD
Topotecan—Feeling abnormal—Dactinomycin—skin cancer	0.000118	0.00114	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000118	0.00114	CcSEcCtD
Topotecan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000117	0.00113	CcSEcCtD
Topotecan—Nervous system disorder—Fluorouracil—skin cancer	0.000117	0.00113	CcSEcCtD
Topotecan—Thrombocytopenia—Fluorouracil—skin cancer	0.000116	0.00112	CcSEcCtD
Topotecan—Paraesthesia—Temozolomide—skin cancer	0.000116	0.00112	CcSEcCtD
Topotecan—Dyspnoea—Temozolomide—skin cancer	0.000115	0.00111	CcSEcCtD
Topotecan—Dyspepsia—Temozolomide—skin cancer	0.000114	0.0011	CcSEcCtD
Topotecan—Anorexia—Fluorouracil—skin cancer	0.000113	0.00109	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—skin cancer	0.000113	0.00109	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—skin cancer	0.000113	0.00109	CcSEcCtD
Topotecan—Hypersensitivity—Bleomycin—skin cancer	0.000113	0.00109	CcSEcCtD
Topotecan—Decreased appetite—Temozolomide—skin cancer	0.000112	0.00108	CcSEcCtD
Topotecan—Gastrointestinal disorder—Temozolomide—skin cancer	0.000111	0.00108	CcSEcCtD
Topotecan—Fatigue—Temozolomide—skin cancer	0.000111	0.00107	CcSEcCtD
Topotecan—Pain—Temozolomide—skin cancer	0.00011	0.00107	CcSEcCtD
Topotecan—Constipation—Temozolomide—skin cancer	0.00011	0.00107	CcSEcCtD
Topotecan—Asthenia—Bleomycin—skin cancer	0.00011	0.00106	CcSEcCtD
Topotecan—Angiopathy—Docetaxel—skin cancer	0.00011	0.00106	CcSEcCtD
Topotecan—Immune system disorder—Docetaxel—skin cancer	0.000109	0.00105	CcSEcCtD
Topotecan—Mediastinal disorder—Docetaxel—skin cancer	0.000109	0.00105	CcSEcCtD
Topotecan—Chills—Docetaxel—skin cancer	0.000108	0.00105	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000108	0.00105	CcSEcCtD
Topotecan—Pruritus—Bleomycin—skin cancer	0.000108	0.00105	CcSEcCtD
Topotecan—Paraesthesia—Fluorouracil—skin cancer	0.000107	0.00103	CcSEcCtD
Topotecan—Alopecia—Docetaxel—skin cancer	0.000107	0.00103	CcSEcCtD
Topotecan—ABCB1—blood vessel—skin cancer	0.000107	0.0354	CbGeAlD
Topotecan—Feeling abnormal—Temozolomide—skin cancer	0.000106	0.00103	CcSEcCtD
Topotecan—Dyspnoea—Fluorouracil—skin cancer	0.000106	0.00102	CcSEcCtD
Topotecan—Gastrointestinal pain—Temozolomide—skin cancer	0.000106	0.00102	CcSEcCtD
Topotecan—Malnutrition—Docetaxel—skin cancer	0.000105	0.00102	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—skin cancer	0.000105	0.00102	CcSEcCtD
Topotecan—Dyspepsia—Fluorouracil—skin cancer	0.000105	0.00101	CcSEcCtD
Topotecan—Decreased appetite—Fluorouracil—skin cancer	0.000103	0.000998	CcSEcCtD
Topotecan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000103	0.000992	CcSEcCtD
Topotecan—Urticaria—Temozolomide—skin cancer	0.000103	0.00099	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—skin cancer	0.000102	0.000989	CcSEcCtD
Topotecan—Body temperature increased—Temozolomide—skin cancer	0.000102	0.000985	CcSEcCtD
Topotecan—Abdominal pain—Temozolomide—skin cancer	0.000102	0.000985	CcSEcCtD
Topotecan—Back pain—Docetaxel—skin cancer	0.000102	0.000982	CcSEcCtD
Topotecan—Pain—Fluorouracil—skin cancer	0.000102	0.000982	CcSEcCtD
Topotecan—Muscle spasms—Docetaxel—skin cancer	0.000101	0.000977	CcSEcCtD
Topotecan—Feeling abnormal—Fluorouracil—skin cancer	9.8e-05	0.000946	CcSEcCtD
Topotecan—Diarrhoea—Dactinomycin—skin cancer	9.77e-05	0.000943	CcSEcCtD
Topotecan—Vomiting—Bleomycin—skin cancer	9.73e-05	0.00094	CcSEcCtD
Topotecan—Anaemia—Docetaxel—skin cancer	9.72e-05	0.000939	CcSEcCtD
Topotecan—Rash—Bleomycin—skin cancer	9.65e-05	0.000932	CcSEcCtD
Topotecan—Dermatitis—Bleomycin—skin cancer	9.64e-05	0.000931	CcSEcCtD
Topotecan—Hypersensitivity—Temozolomide—skin cancer	9.51e-05	0.000918	CcSEcCtD
Topotecan—Urticaria—Fluorouracil—skin cancer	9.45e-05	0.000912	CcSEcCtD
Topotecan—Leukopenia—Docetaxel—skin cancer	9.42e-05	0.000909	CcSEcCtD
Topotecan—Body temperature increased—Fluorouracil—skin cancer	9.4e-05	0.000908	CcSEcCtD
Topotecan—Asthenia—Temozolomide—skin cancer	9.26e-05	0.000894	CcSEcCtD
Topotecan—Cough—Docetaxel—skin cancer	9.18e-05	0.000886	CcSEcCtD
Topotecan—Pruritus—Temozolomide—skin cancer	9.13e-05	0.000882	CcSEcCtD
Topotecan—ABCG2—mammalian vulva—skin cancer	9.13e-05	0.0303	CbGeAlD
Topotecan—Nausea—Bleomycin—skin cancer	9.09e-05	0.000878	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—skin cancer	9.08e-05	0.000876	CcSEcCtD
Topotecan—Rash—Dactinomycin—skin cancer	9e-05	0.000869	CcSEcCtD
Topotecan—Chest pain—Docetaxel—skin cancer	8.96e-05	0.000865	CcSEcCtD
Topotecan—Arthralgia—Docetaxel—skin cancer	8.96e-05	0.000865	CcSEcCtD
Topotecan—Myalgia—Docetaxel—skin cancer	8.96e-05	0.000865	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	8.89e-05	0.000859	CcSEcCtD
Topotecan—Diarrhoea—Temozolomide—skin cancer	8.83e-05	0.000853	CcSEcCtD
Topotecan—Hypersensitivity—Fluorouracil—skin cancer	8.76e-05	0.000846	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—skin cancer	8.59e-05	0.000829	CcSEcCtD
Topotecan—Dizziness—Temozolomide—skin cancer	8.54e-05	0.000824	CcSEcCtD
Topotecan—Infection—Docetaxel—skin cancer	8.53e-05	0.000824	CcSEcCtD
Topotecan—Nausea—Dactinomycin—skin cancer	8.48e-05	0.000819	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—skin cancer	8.42e-05	0.000813	CcSEcCtD
Topotecan—Pruritus—Fluorouracil—skin cancer	8.42e-05	0.000813	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—skin cancer	8.41e-05	0.000812	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—skin cancer	8.34e-05	0.000805	CcSEcCtD
Topotecan—Vomiting—Temozolomide—skin cancer	8.21e-05	0.000793	CcSEcCtD
Topotecan—Anorexia—Docetaxel—skin cancer	8.18e-05	0.00079	CcSEcCtD
Topotecan—Rash—Temozolomide—skin cancer	8.14e-05	0.000786	CcSEcCtD
Topotecan—Diarrhoea—Fluorouracil—skin cancer	8.14e-05	0.000786	CcSEcCtD
Topotecan—Dermatitis—Temozolomide—skin cancer	8.13e-05	0.000785	CcSEcCtD
Topotecan—Headache—Temozolomide—skin cancer	8.09e-05	0.000781	CcSEcCtD
Topotecan—Dizziness—Fluorouracil—skin cancer	7.87e-05	0.000759	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—skin cancer	7.82e-05	0.000755	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—skin cancer	7.71e-05	0.000744	CcSEcCtD
Topotecan—Nausea—Temozolomide—skin cancer	7.67e-05	0.00074	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—skin cancer	7.65e-05	0.000739	CcSEcCtD
Topotecan—Vomiting—Fluorouracil—skin cancer	7.56e-05	0.00073	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—skin cancer	7.56e-05	0.00073	CcSEcCtD
Topotecan—Rash—Fluorouracil—skin cancer	7.5e-05	0.000724	CcSEcCtD
Topotecan—Dermatitis—Fluorouracil—skin cancer	7.49e-05	0.000723	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—skin cancer	7.46e-05	0.000721	CcSEcCtD
Topotecan—Headache—Fluorouracil—skin cancer	7.45e-05	0.000719	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—skin cancer	7.41e-05	0.000716	CcSEcCtD
Topotecan—Fatigue—Docetaxel—skin cancer	7.4e-05	0.000715	CcSEcCtD
Topotecan—Pain—Docetaxel—skin cancer	7.34e-05	0.000709	CcSEcCtD
Topotecan—Constipation—Docetaxel—skin cancer	7.34e-05	0.000709	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—skin cancer	7.07e-05	0.000683	CcSEcCtD
Topotecan—Nausea—Fluorouracil—skin cancer	7.07e-05	0.000682	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—skin cancer	7.02e-05	0.000678	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—skin cancer	6.79e-05	0.000655	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—skin cancer	6.79e-05	0.000655	CcSEcCtD
Topotecan—Hypersensitivity—Docetaxel—skin cancer	6.33e-05	0.000611	CcSEcCtD
Topotecan—Asthenia—Docetaxel—skin cancer	6.16e-05	0.000595	CcSEcCtD
Topotecan—Pruritus—Docetaxel—skin cancer	6.07e-05	0.000586	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—skin cancer	5.87e-05	0.000567	CcSEcCtD
Topotecan—Dizziness—Docetaxel—skin cancer	5.68e-05	0.000548	CcSEcCtD
Topotecan—Vomiting—Docetaxel—skin cancer	5.46e-05	0.000527	CcSEcCtD
Topotecan—CYP3A4—female reproductive system—skin cancer	5.45e-05	0.0181	CbGeAlD
Topotecan—Rash—Docetaxel—skin cancer	5.41e-05	0.000523	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—skin cancer	5.41e-05	0.000522	CcSEcCtD
Topotecan—Headache—Docetaxel—skin cancer	5.38e-05	0.000519	CcSEcCtD
Topotecan—ABCB1—epithelium—skin cancer	5.19e-05	0.0172	CbGeAlD
Topotecan—Nausea—Docetaxel—skin cancer	5.1e-05	0.000492	CcSEcCtD
Topotecan—ABCG2—lymph node—skin cancer	4.57e-05	0.0152	CbGeAlD
Topotecan—ABCB1—mammalian vulva—skin cancer	4.5e-05	0.0149	CbGeAlD
Topotecan—ABCB1—lymphoid tissue—skin cancer	4e-05	0.0133	CbGeAlD
Topotecan—ABCB1—female reproductive system—skin cancer	3.85e-05	0.0128	CbGeAlD
Topotecan—ABCB1—head—skin cancer	3.22e-05	0.0107	CbGeAlD
Topotecan—ABCB1—lymph node—skin cancer	2.25e-05	0.00748	CbGeAlD
